Domagrozumab (PF-06252616) 10mg

Domagrozumab (PF-06252616) 10mg

Brand: RCpeptides
4000.00 EUR In stock Buy at Merchant

Domagrozumab PF-06252616 is a humanized monoclonal antibody used to neutralize myostatin, aiming to increase muscle mass and improve strength in certain muscular dystrophies.

  • The therapeutic premise is that sustained myostatin blockade would increase lean muscle mass and improve strength and function in diseases like Duchenne muscular dystrophy.
  • Regulatory status: investigational; not FDA/EMA-approved.
Variants (1)
  • Default Title — 4000.00 EUR — In stock

How AI sees this product

The more complete this product's details, the more confidently AI assistants can understand and recommend it.

66%
4 details missing that AI looks for Claim to see how to fix it
Data sourced from rcpeptides.com. Last updated: This description was written with AI from the merchant's product information, so some details may vary.
Claim rcpeptides.com to control what AI sees, no website changes

Takes ~2 minutes. No changes to your website.